Literature DB >> 9720552

Prognostic indicators in patients with seminal vesicle involvement following radical prostatectomy for clinically localized prostate cancer.

M V Tefilli1, E L Gheiler, R Tiguert, M Banerjee, W Sakr, D J Grignon, J E Pontes, D P Wood.   

Abstract

PURPOSE: We identify prognostic factors in patients with seminal vesicle involvement and negative lymph nodes following radical prostatectomy for clinically localized prostate cancer.
MATERIALS AND METHODS: A total of 93 patients who underwent radical prostatectomy and had seminal vesicle invasion without lymph node metastasis were evaluated. Patients who underwent neoadjuvant/adjuvant hormonal or radiation therapy were excluded from study. Preoperative serum prostate specific antigen (PSA), biopsy and radical prostatectomy specimen Gleason score, surgical margin status, presence of extraprostatic extension and evidence of biochemical disease progression were determined prospectively. Biochemical failure was defined as a single serum PSA elevation greater than 0.4 ng./ml.
RESULTS: The presence of positive surgical margins (p = 0.001), and Gleason score 7 or higher from preoperative biopsies (p = 0.03) and from the radical prostatectomy specimen (p = 0.01) were significant predictors of disease progression at a median followup of 43.3 months. Patients with preoperative PSA less than 10 ng./ml. had a better disease-free survival (p = 0.07). On multivariate analysis, after adjusting for biopsy Gleason score, prostatectomy Gleason score and serum PSA, positive surgical margins remained a statistically significant predictor of disease progression (p = 0.002).
CONCLUSIONS: Surgical margin status is an independent predictor of disease recurrence in patients with seminal vesicle involvement and negative lymph nodes following radical prostatectomy. Serum PSA 10 ng./ml. or greater and specimen Gleason score 7 or greater also were adverse prognostic factors in these patients. Conversely, patients with negative surgical margins and lymph nodes have a better prognosis than previously expected, despite seminal vesicle invasion.

Entities:  

Mesh:

Year:  1998        PMID: 9720552     DOI: 10.1097/00005392-199809010-00047

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  7 in total

1.  Seminal vesicle invasion by prostate cancer: prognostic significance and therapeutic implications.

Authors:  S R Potter; J I Epstein; A W Partin
Journal:  Rev Urol       Date:  2000

2.  A contemporary analysis of outcomes of adenocarcinoma of the prostate with seminal vesicle invasion (pT3b) after radical prostatectomy.

Authors:  Phillip M Pierorazio; Ashley E Ross; Edward M Schaeffer; Jonathan I Epstein; Misop Han; Patrick C Walsh; Alan W Partin
Journal:  J Urol       Date:  2011-03-21       Impact factor: 7.450

Review 3.  The Gordon Wilson Lecture. Natural history and treatment of early stage prostate cancer.

Authors:  P T Scardino
Journal:  Trans Am Clin Climatol Assoc       Date:  2000

4.  The prognostic impact of seminal vesicle involvement found at prostatectomy and the effects of adjuvant radiation: data from Southwest Oncology Group 8794.

Authors:  Gregory P Swanson; Bryan Goldman; Catherine M Tangen; Joseph Chin; Edward Messing; Edith Canby-Hagino; Jeffrey D Forman; Ian M Thompson; E David Crawford
Journal:  J Urol       Date:  2008-10-19       Impact factor: 7.450

5.  Prognostic factors for failure after prostatectomy.

Authors:  Gregory P Swanson; Joseph W Basler
Journal:  J Cancer       Date:  2010-12-07       Impact factor: 4.207

6.  Association between Seminal Vesicle Invasion and Prostate Cancer Detection Location after Transrectal Systemic Biopsy among Men Who Underwent Radical Prostatectomy.

Authors:  Young Ik Lee; Hak Min Lee; Jung Ki Jo; Sangchul Lee; Sung Kyu Hong; Seok-Soo Byun; Sang Eun Lee; Jong Jin Oh
Journal:  PLoS One       Date:  2016-02-05       Impact factor: 3.240

7.  Laparoscopic radical prostatectomy outcome data: how should surgeon's performance be reported? A retrospective learning curve analysis of two surgeons.

Authors:  Sarah Mason; Mieke Van Hemelrijck; Ashish Chandra; Christian Brown; Declan Cahill
Journal:  Ecancermedicalscience       Date:  2016-07-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.